Open access · CC-BY
via OpenAlex
Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives
Christian Sávio-Silva, Poliana E. Soinski-Sousa, Maria Theresa A Balby-Rocha, Ádyna de Oliveira Lira, Érika Bevilaqua Rangel
Revista da Associação Médica Brasileira · 2020 · ▲ 45 citations
Abstract
INTRODUCTION: Acute kidney injury (AKI) is highly prevalent today. It has a multifactorial aetiology and affects people of all ages, genders and ethnicities. Its treatment is essentially supportive of renal function substitution, so new treatment alternatives such as mesenchymal stem cell therapy (MSCs) should be investigated. METHODS: This review encompasses our understanding of the main mechanisms of action of MSCs in preclinical models of AKI by renal pedicle clamping ischemia-reperfusion, chemotherapy (cisplatin) and kidney transplantation in small and large animals, as well as outcomes in patients with AKI due to ischemia and kidney transplantation. RESULTS: Cellular therapy with MSCs has benefits in preclinical studies of AKI through various mechanisms, such as anti-inflammatory, antiapoptotic, oxidative anti-stress, antifibrotic, immunomodulatory and proangiogenic. In humans, MSC therapy is safe and effective. However, the challenges of MSC cell therapy include investigating protocols about the optimal dose of these cells, the route and frequency of appropriate administration, and the design of further biodistribution studies over a long follow-up period. In addition, a better understanding of molecular signalling and cellular interactions in the microenvironment of each organ and tissue is needed in order to define the best time to administer MSCs. Another challenge would be to mitigate the heterogeneity of the profile of cultured MSCs through preconditioning approaches. CONCLUSIONS: Cellular therapy with MSCs is very promising and should be part of the treatment of AKI patients in combination with other approaches already available, helping to accelerate recovery and/or slow the progression to chronic kidney disease. Randomized, multicentre controlled studies are needed to develop robust protocols that validate population-based cell therapy with MSCs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1590/1806-9282.66.s1.45
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Sávio-Silva, C., Soinski-Sousa, P.E., Balby-Rocha, M.T.A., Lira, �.D.O., & Rangel, �.B. (2020). Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives. <em>Revista da Associação Médica Brasileira</em>. https://doi.org/10.1590/1806-9282.66.s1.45
Vancouver
Sávio-Silva C, Soinski-Sousa PE, Balby-Rocha MTA, Lira �DO, Rangel �B. Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives. Revista da Associação Médica Brasileira. 2020. doi:10.1590/1806-9282.66.s1.45.
BibTeX
@article{christian2020Mesenc,
title = {Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives},
author = {Christian Sávio-Silva and Poliana E. Soinski-Sousa and Maria Theresa A Balby-Rocha and Ádyna de Oliveira Lira and Érika Bevilaqua Rangel},
journal = {Revista da Associação Médica Brasileira},
year = {2020},
doi = {10.1590/1806-9282.66.s1.45},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Transplantation 2023
Open access · CC-BY
Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges
Frontiers in Cellular Neuroscience 2021
Open access · CC-BY
Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges
Libyan Journal of Medical Research 2025
Open access · CC-BY
Klotho gene transfection into mesenchymal stem cells as a potential therapy for kidney disease
Frontiers in Neurology 2019
Open access · CC-BY
Mesenchymal Stem Cell-Derived Extracellular Vesicle Therapy for Stroke: Challenges and Progress
Stem Cells International 2021
Open access · CC-BY
Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke
PubMed 2017
Preprint · OA